Randomized controlled feasibility trial of supported self‐management in adults with Type 2 diabetes mellitus and an intellectual disability: OK Diabetes
Aims To undertake a feasibility randomized controlled trial of supported self‐management vs treatment as usual in a population of adults with obesity, Type 2 diabetes and an intellectual disability. Methods We conducted an individually randomized feasibility trial. Participants were adults aged >...
Saved in:
Published in | Diabetic medicine Vol. 35; no. 6; pp. 776 - 788 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.06.2018
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aims
To undertake a feasibility randomized controlled trial of supported self‐management vs treatment as usual in a population of adults with obesity, Type 2 diabetes and an intellectual disability.
Methods
We conducted an individually randomized feasibility trial. Participants were adults aged >18 years with a mild or moderate intellectual disability, living in the community with Type 2 diabetes, on any therapy other than insulin. Participants had mental capacity to consent to research and the intervention. Inclusion criteria included HbA1c > 48 mmol/mol (6.5%), BMI >25 kg/m2, or self‐reported physical activity below national guideline levels. The experimental intervention was standardized supported self‐management delivered by diabetes specialist nurses plus treatment as usual, compared with treatment as usual alone. Feasibility outcomes included: recruitment and retention; intervention acceptability and feasibility; data collection and completeness for physiological state and values for candidate primary outcomes (HbA1c and BMI).
Results
A total of 82 participants (89% of those contacted and eligible) were randomized. All supported self‐management sessions were completed by 35/41 participants (85%); only four completed no sessions. Data on the follow‐up candidate primary outcomes HbA1c and BMI were obtained for 75/82 (91%) and 77/82 participants (94%), respectively. The mean baseline HbA1c was 56±16.5 mmol/mol (7.3±1.5%) and the mean BMI was 34±7.6 kg/m2.
Conclusions
Adherence to supported self‐management and willingness to have blood taken for outcome measurement was good. A definitive randomized controlled trial is feasible in this population.
(Trial registration: Current Controlled Trials ISRCTN41897033)
What's new?
This is the largest published randomized study of Type 2 diabetes mellitus self‐management in community‐living adults with an intellectual disability.
Recruitment was 89% of contacted eligible respondents.
Over 90% of randomized participants were retained in the study, with primary outcome data collected at follow‐up.
Adherence to self‐management was good; 85% completed all sessions.
HbA1c levels were in line with general population rates for Type 2 diabetes.
Obesity and physical inactivity were a major problem.
We have demonstrated the feasibility of conducting a definitive phase III trial in adults with an intellectual disability. |
---|---|
AbstractList | AIMSTo undertake a feasibility randomized controlled trial of supported self-management vs treatment as usual in a population of adults with obesity, Type 2 diabetes and an intellectual disability.METHODSWe conducted an individually randomized feasibility trial. Participants were adults aged >18 years with a mild or moderate intellectual disability, living in the community with Type 2 diabetes, on any therapy other than insulin. Participants had mental capacity to consent to research and the intervention. Inclusion criteria included HbA1c > 48 mmol/mol (6.5%), BMI >25 kg/m2 , or self-reported physical activity below national guideline levels. The experimental intervention was standardized supported self-management delivered by diabetes specialist nurses plus treatment as usual, compared with treatment as usual alone. Feasibility outcomes included: recruitment and retention; intervention acceptability and feasibility; data collection and completeness for physiological state and values for candidate primary outcomes (HbA1c and BMI).RESULTSA total of 82 participants (89% of those contacted and eligible) were randomized. All supported self-management sessions were completed by 35/41 participants (85%); only four completed no sessions. Data on the follow-up candidate primary outcomes HbA1c and BMI were obtained for 75/82 (91%) and 77/82 participants (94%), respectively. The mean baseline HbA1c was 56±16.5 mmol/mol (7.3±1.5%) and the mean BMI was 34±7.6 kg/m2 .CONCLUSIONSAdherence to supported self-management and willingness to have blood taken for outcome measurement was good. A definitive randomized controlled trial is feasible in this population. (Trial registration: Current Controlled Trials ISRCTN41897033). To undertake a feasibility randomized controlled trial of supported self-management vs treatment as usual in a population of adults with obesity, Type 2 diabetes and an intellectual disability. We conducted an individually randomized feasibility trial. Participants were adults aged >18 years with a mild or moderate intellectual disability, living in the community with Type 2 diabetes, on any therapy other than insulin. Participants had mental capacity to consent to research and the intervention. Inclusion criteria included HbA > 48 mmol/mol (6.5%), BMI >25 kg/m , or self-reported physical activity below national guideline levels. The experimental intervention was standardized supported self-management delivered by diabetes specialist nurses plus treatment as usual, compared with treatment as usual alone. Feasibility outcomes included: recruitment and retention; intervention acceptability and feasibility; data collection and completeness for physiological state and values for candidate primary outcomes (HbA and BMI). A total of 82 participants (89% of those contacted and eligible) were randomized. All supported self-management sessions were completed by 35/41 participants (85%); only four completed no sessions. Data on the follow-up candidate primary outcomes HbA and BMI were obtained for 75/82 (91%) and 77/82 participants (94%), respectively. The mean baseline HbA was 56±16.5 mmol/mol (7.3±1.5%) and the mean BMI was 34±7.6 kg/m . Adherence to supported self-management and willingness to have blood taken for outcome measurement was good. A definitive randomized controlled trial is feasible in this population. (Trial registration: Current Controlled Trials ISRCTN41897033). Aims To undertake a feasibility randomized controlled trial of supported self‐management vs treatment as usual in a population of adults with obesity, Type 2 diabetes and an intellectual disability. Methods We conducted an individually randomized feasibility trial. Participants were adults aged >18 years with a mild or moderate intellectual disability, living in the community with Type 2 diabetes, on any therapy other than insulin. Participants had mental capacity to consent to research and the intervention. Inclusion criteria included HbA1c > 48 mmol/mol (6.5%), BMI >25 kg/m2, or self‐reported physical activity below national guideline levels. The experimental intervention was standardized supported self‐management delivered by diabetes specialist nurses plus treatment as usual, compared with treatment as usual alone. Feasibility outcomes included: recruitment and retention; intervention acceptability and feasibility; data collection and completeness for physiological state and values for candidate primary outcomes (HbA1c and BMI). Results A total of 82 participants (89% of those contacted and eligible) were randomized. All supported self‐management sessions were completed by 35/41 participants (85%); only four completed no sessions. Data on the follow‐up candidate primary outcomes HbA1c and BMI were obtained for 75/82 (91%) and 77/82 participants (94%), respectively. The mean baseline HbA1c was 56±16.5 mmol/mol (7.3±1.5%) and the mean BMI was 34±7.6 kg/m2. Conclusions Adherence to supported self‐management and willingness to have blood taken for outcome measurement was good. A definitive randomized controlled trial is feasible in this population. (Trial registration: Current Controlled Trials ISRCTN41897033) What's new? This is the largest published randomized study of Type 2 diabetes mellitus self‐management in community‐living adults with an intellectual disability. Recruitment was 89% of contacted eligible respondents. Over 90% of randomized participants were retained in the study, with primary outcome data collected at follow‐up. Adherence to self‐management was good; 85% completed all sessions. HbA1c levels were in line with general population rates for Type 2 diabetes. Obesity and physical inactivity were a major problem. We have demonstrated the feasibility of conducting a definitive phase III trial in adults with an intellectual disability. This is the largest published randomized study of Type 2 diabetes mellitus self‐management in community‐living adults with an intellectual disability. Recruitment was 89% of contacted eligible respondents. Over 90% of randomized participants were retained in the study, with primary outcome data collected at follow‐up. Adherence to self‐management was good; 85% completed all sessions. HbA 1c levels were in line with general population rates for Type 2 diabetes. Obesity and physical inactivity were a major problem. We have demonstrated the feasibility of conducting a definitive phase III trial in adults with an intellectual disability. Abstract Aims To undertake a feasibility randomized controlled trial of supported self‐management vs treatment as usual in a population of adults with obesity, Type 2 diabetes and an intellectual disability. Methods We conducted an individually randomized feasibility trial. Participants were adults aged >18 years with a mild or moderate intellectual disability, living in the community with Type 2 diabetes, on any therapy other than insulin. Participants had mental capacity to consent to research and the intervention. Inclusion criteria included HbA 1c > 48 mmol/mol (6.5%), BMI >25 kg/m 2 , or self‐reported physical activity below national guideline levels. The experimental intervention was standardized supported self‐management delivered by diabetes specialist nurses plus treatment as usual, compared with treatment as usual alone. Feasibility outcomes included: recruitment and retention; intervention acceptability and feasibility; data collection and completeness for physiological state and values for candidate primary outcomes (HbA 1c and BMI ). Results A total of 82 participants (89% of those contacted and eligible) were randomized. All supported self‐management sessions were completed by 35/41 participants (85%); only four completed no sessions. Data on the follow‐up candidate primary outcomes HbA 1c and BMI were obtained for 75/82 (91%) and 77/82 participants (94%), respectively. The mean baseline HbA 1c was 56±16.5 mmol/mol (7.3±1.5%) and the mean BMI was 34±7.6 kg/m 2 . Conclusions Adherence to supported self‐management and willingness to have blood taken for outcome measurement was good. A definitive randomized controlled trial is feasible in this population. (Trial registration: Current Controlled Trials ISRCTN 41897033) What's new? This is the largest published randomized study of Type 2 diabetes mellitus self‐management in community‐living adults with an intellectual disability. Recruitment was 89% of contacted eligible respondents. Over 90% of randomized participants were retained in the study, with primary outcome data collected at follow‐up. Adherence to self‐management was good; 85% completed all sessions. HbA 1c levels were in line with general population rates for Type 2 diabetes. Obesity and physical inactivity were a major problem. We have demonstrated the feasibility of conducting a definitive phase III trial in adults with an intellectual disability. |
Author | Wright, J. M. Ajjan, R. Bryant, L. O'Dwyer, J. L Latchford, G. Wright‐Hughes, A. Graham, L. Stansfield, A. House, A. Russell, A. M. Hulme, C. Walwyn, R. Farrin, A. |
AuthorAffiliation | 1 Leeds Institute of Health Sciences University of Leeds Leeds UK 2 Clinical Trials Research Unit University of Leeds Leeds UK 3 Leeds York Partnerships NHS Foundation Trust Leeds UK 4 Division of Cardiovascular and Diabetes Research University of Leeds Leeds UK |
AuthorAffiliation_xml | – name: 3 Leeds York Partnerships NHS Foundation Trust Leeds UK – name: 1 Leeds Institute of Health Sciences University of Leeds Leeds UK – name: 2 Clinical Trials Research Unit University of Leeds Leeds UK – name: 4 Division of Cardiovascular and Diabetes Research University of Leeds Leeds UK |
Author_xml | – sequence: 1 givenname: A. orcidid: 0000-0001-8721-8026 surname: House fullname: House, A. email: a.o.house@leeds.ac.uk organization: University of Leeds – sequence: 2 givenname: L. orcidid: 0000-0002-1972-7395 surname: Bryant fullname: Bryant, L. organization: University of Leeds – sequence: 3 givenname: A. M. surname: Russell fullname: Russell, A. M. organization: University of Leeds – sequence: 4 givenname: A. surname: Wright‐Hughes fullname: Wright‐Hughes, A. organization: University of Leeds – sequence: 5 givenname: L. surname: Graham fullname: Graham, L. organization: University of Leeds – sequence: 6 givenname: R. surname: Walwyn fullname: Walwyn, R. organization: University of Leeds – sequence: 7 givenname: J. M. surname: Wright fullname: Wright, J. M. organization: University of Leeds – sequence: 8 givenname: C. surname: Hulme fullname: Hulme, C. organization: University of Leeds – sequence: 9 givenname: J. L surname: O'Dwyer fullname: O'Dwyer, J. L organization: University of Leeds – sequence: 10 givenname: G. surname: Latchford fullname: Latchford, G. organization: University of Leeds – sequence: 11 givenname: A. surname: Stansfield fullname: Stansfield, A. organization: Leeds York Partnerships NHS Foundation Trust – sequence: 12 givenname: R. surname: Ajjan fullname: Ajjan, R. organization: University of Leeds – sequence: 13 givenname: A. surname: Farrin fullname: Farrin, A. organization: University of Leeds |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29575241$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc9qFTEUxoO02NvqwheQgBtdTJtkMn_iQpC2_sFKQeo6nJmctCkzyXWSsVxXPoJrH88nMXauRQUDISHnl--cj2-f7PjgkZBHnB3yvI7MiIe8rEV9j6y4rGVRScV3yIo1UhQla_ge2Y_xmjEuVKnukz2hqqYSkq_I9w_gTRjdFzS0Dz5NYRjy1SJE17nBpQ1Nk4OBBkvjvF6HKeVyxMH--PptBA-XOKJP1HkKZh5SpDcuXdGLzRqpoMZBhwkjHXHIWnOkuVveGU_5Bfs0Z2njIiy9ntPzd_Rk--kB2bUwRHy4PQ_Ix1enF8dvirPz12-PX54VvZRlXTRomelQcZSWcQBhseoqtCVrQQjDVWsrQN50PeetlMBLa5jiIHqQAArKA_Ji0V3P3Yimz3YmGPR6ciNMGx3A6b8r3l3py_BZV6pWom2zwNOtwBQ-zRiTHl3ssz_wGOaoBeNtXTeNaDL65B_0OsyTz_YyVbacta2qMvVsofopxDihvRuGM_0rcZ0T17eJZ_bxn9Pfkb8jzsDRAty4ATf_V9In708XyZ8tf7xz |
CitedBy_id | crossref_primary_10_1136_bmjopen_2021_056532 crossref_primary_10_1108_TLDR_11_2019_0035 crossref_primary_10_1186_s40814_018_0357_6 crossref_primary_10_1186_s40814_018_0291_7 crossref_primary_10_1007_s40474_018_0142_5 crossref_primary_10_1111_jir_13098 crossref_primary_10_3310_hta22260 crossref_primary_10_7748_phc_29_1_12_s13 crossref_primary_10_1111_dme_13646 |
Cites_doi | 10.3310/hta22260 10.1186/s12874-016-0236-x 10.1016/j.pec.2013.08.016 10.1016/j.jand.2014.07.005 10.1016/S0140-6736(04)17277-2 10.1111/j.1741-1130.2011.00314.x 10.1016/j.jpsychores.2004.09.006 10.1001/jama.2014.14173 10.1111/j.1365-2648.2011.05860.x 10.1177/014572179802400504 10.7326/M15-0452 10.1111/j.1468-3148.2006.00263.x 10.1111/j..2002.384.doc.x 10.1111/j.1467-789X.2006.00296.x 10.1111/j.1365-2788.2011.01472.x 10.1177/1074840712471899 10.7326/M14-0130 10.1186/s13063-015-0832-9 10.1111/dme.13510 10.1002/edn.160 10.1186/1741-7015-11-75 10.1352/1934-9556-49.3.155 10.1111/jir.12100 |
ContentType | Journal Article |
Copyright | 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. Diabetic Medicine © 2018 Diabetes UK |
Copyright_xml | – notice: 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK – notice: 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. – notice: Diabetic Medicine © 2018 Diabetes UK |
DBID | 24P WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 8FD FR3 H94 K9. P64 RC3 7X8 5PM |
DOI | 10.1111/dme.13626 |
DatabaseName | Wiley Open Access Wiley-Blackwell Backfiles (Open access) Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Genetics Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: 24P name: Wiley-Blackwell Open Access Collection url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Nursing |
DocumentTitleAlternate | A. House et al |
EISSN | 1464-5491 |
EndPage | 788 |
ExternalDocumentID | 10_1111_dme_13626 29575241 DME13626 |
Genre | article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: National Institute for Health Research Health Technology Assessment programme – fundername: NIHR HTA funderid: 10/102/03 – fundername: Department of Health grantid: 10/102/03 – fundername: NIHR HTA grantid: 10/102/03 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 24P 29F 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RWI RX1 SAMSI SUPJJ TEORI UB1 V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 XV2 YFH YUY ZGI ZXP ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 8FD FR3 H94 K9. P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c4436-7ef0dbe91e4f01aa2fe5b5ef308a22d198f5ae17bc11844a13fd091a2ca4aa9a3 |
IEDL.DBID | 24P |
ISSN | 0742-3071 |
IngestDate | Tue Sep 17 21:26:25 EDT 2024 Sat Aug 17 03:08:44 EDT 2024 Thu Oct 10 14:48:45 EDT 2024 Fri Aug 23 00:54:56 EDT 2024 Sat Nov 02 12:24:17 EDT 2024 Sat Aug 24 00:59:05 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
License | Attribution-NonCommercial 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4436-7ef0dbe91e4f01aa2fe5b5ef308a22d198f5ae17bc11844a13fd091a2ca4aa9a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-1972-7395 0000-0001-8721-8026 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdme.13626 |
PMID | 29575241 |
PQID | 2038108895 |
PQPubID | 1006515 |
PageCount | 13 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5969288 proquest_miscellaneous_2018667727 proquest_journals_2038108895 crossref_primary_10_1111_dme_13626 pubmed_primary_29575241 wiley_primary_10_1111_dme_13626_DME13626 |
PublicationCentury | 2000 |
PublicationDate | June 2018 |
PublicationDateYYYYMMDD | 2018-06-01 |
PublicationDate_xml | – month: 06 year: 2018 text: June 2018 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: Hoboken |
PublicationTitle | Diabetic medicine |
PublicationTitleAlternate | Diabet Med |
PublicationYear | 2018 |
Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
References | 2004; 364 2015; 163 2015; 16 2012 2011 2010 2013; 93 2006; 19 2012; 56 2016; 16 2007; 57 2011; 8 2014; 114 2014; 312 1998; 24 2013; 19 2004; 10 2001 2001; 7 2013; 11 2007; 8 2014; 58 2018 2014; 161 2016; 60 2011; 49 2012; 68 2010; 7 2018; 35 2005; 58 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_10_1 Glover G (e_1_2_9_5_1) 2012 e_1_2_9_15_1 Department of Health (e_1_2_9_8_1) 2001 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_21_1 e_1_2_9_24_1 Straetmans JM (e_1_2_9_2_1) 2007; 57 e_1_2_9_23_1 Department of Health (e_1_2_9_22_1) 2011 e_1_2_9_7_1 e_1_2_9_6_1 e_1_2_9_4_1 e_1_2_9_3_1 Braddock D (e_1_2_9_13_1) 2001; 7 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 Taggart L (e_1_2_9_12_1) 2016; 60 e_1_2_9_28_1 e_1_2_9_27_1 e_1_2_9_29_1 |
References_xml | – volume: 58 start-page: 851 year: 2014 end-page: 863 article-title: Obesity and associated factors in adults with intellectual disability publication-title: J Intellect Disabil Res – year: 2011 – volume: 8 start-page: 223 year: 2011 end-page: 230 article-title: Self‐management abilities of diabetes in people with an intellectual disability living in New Zealand publication-title: J Policy Pract Intellect Disabil – volume: 163 start-page: 437 year: 2015 end-page: 451 article-title: Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force publication-title: Ann Intern Med – volume: 19 start-page: 285 year: 2006 end-page: 295 article-title: The social networks of people with intellectual disability living in the community 12 years after resettlement from long‐stay hospitals publication-title: J Appl Res Intellect Disabil – year: 2001 – volume: 49 year: 2011 article-title: Health status and health risks of the ‘hidden majority’ of adults with intellectual disability publication-title: Intellect Dev Disabil – volume: 24 start-page: 599 year: 1998 end-page: 607 article-title: The family and type 2 diabetes: a framework for intervention publication-title: Diabetes Educ – volume: 60 start-page: 746 year: 2016 article-title: Desmond‐id: Outcomes of a pilot feasibility study exploring the Hba1c for adults with intellectual disabilities and type 2 diabetes publication-title: J Intellect Disabil Res – volume: 7 start-page: 71 year: 2010 end-page: 76 article-title: Self‐management interventions for type 2 diabetes: a systematic review publication-title: Eur Diabetes Nurs – year: 2018 – volume: 35 start-page: 352 year: 2018 end-page: 359 article-title: Characterizing adults with Type 2 diabetes mellitus and intellectual disability: outcomes of a case‐finding study publication-title: Diabet Med – year: 2010 – year: 2012 – volume: 56 start-page: 351 year: 2012 end-page: 360 article-title: People with mild to moderate intellectual disability talking about their diabetes and how they manage publication-title: J Intellect Disabil Res – volume: 11 start-page: 75 year: 2013 article-title: Are behavioral interventions effective in increasing physical activity at 12 to 36 months in adults aged 55 to 70 years? A systematic review and meta‐analysis publication-title: BMC Med – volume: 57 start-page: 64 year: 2007 end-page: 66 article-title: Health problems of people with intellectual disabilities: the impact for general practice publication-title: Br J Gen Pract – volume: 10 start-page: 307 year: 2004 end-page: 312 article-title: Design and analysis of pilot studies: recommendations for good practice publication-title: J Eval Clin Pract – volume: 93 start-page: 549 year: 2013 end-page: 558 article-title: Social support and glycemic control in type 2 diabetes: a systematic review of observational studies publication-title: Patient Educ Couns – volume: 7 start-page: 115 year: 2001 end-page: 121 article-title: Living circumstances of children and adults with mental retardation or developmental disabilities in the United States, Canada, England and Wales, and Australia publication-title: Dev Disabil Res Rev – volume: 114 start-page: 1557 year: 2014 end-page: 1568 article-title: Behavioural Weight Management Review Group. Diet or exercise interventions vs combined behavioral weight management programs: a systematic review and meta‐analysis of direct comparisons publication-title: J Acad Nutr Diet – volume: 312 start-page: 1779 year: 2014 end-page: 1791 article-title: Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review publication-title: JAMA – volume: 68 start-page: 496 year: 2012 end-page: 510 article-title: The efficacy of tailored interventions for self‐management outcomes of type 2 diabetes, hypertension or heart disease: a systematic review publication-title: J Adv Nurs – volume: 58 start-page: 163 year: 2005 end-page: 171 article-title: Detecting and monitoring depression with a two‐item questionnaire (PHQ‐2) publication-title: J Psychosom Res – volume: 364 start-page: 1523 year: 2004 end-page: 1537 article-title: Self‐management interventions for chronic illness publication-title: Lancet – volume: 161 start-page: 568 year: 2014 end-page: 578 article-title: Behavioral Counseling to Promote a Healthy Lifestyle in Persons With Cardiovascular Risk Factors: A Systematic Review for the US Preventive Services Task ForceHealthy Lifestyle Counseling in Persons With Cardiovascular Risk Factors publication-title: Ann Intern Med – volume: 16 start-page: 342 year: 2015 article-title: Supported self‐management for adults with type 2 diabetes and a learning disability (OK‐Diabetes): study protocol for a randomised controlled feasibility trial publication-title: Trials – volume: 8 start-page: 223 year: 2007 end-page: 230 article-title: The prevalence and determinants of obesity in adults with intellectual disabilities publication-title: Obes Rev – volume: 16 start-page: 132 year: 2016 article-title: Measurement of adherence in a randomised controlled trial of a complex intervention: supported self‐management for adults with learning disability and type 2 diabetes publication-title: BMC Med Res Methodol – volume: 19 start-page: 3 year: 2013 end-page: 28 article-title: Interrelation between adult persons with diabetes and their family a systematic review of the literature publication-title: J Fam Nurs – ident: e_1_2_9_20_1 doi: 10.3310/hta22260 – ident: e_1_2_9_25_1 doi: 10.1186/s12874-016-0236-x – ident: e_1_2_9_19_1 doi: 10.1016/j.pec.2013.08.016 – ident: e_1_2_9_29_1 doi: 10.1016/j.jand.2014.07.005 – ident: e_1_2_9_9_1 doi: 10.1016/S0140-6736(04)17277-2 – ident: e_1_2_9_3_1 – ident: e_1_2_9_17_1 doi: 10.1111/j.1741-1130.2011.00314.x – ident: e_1_2_9_26_1 doi: 10.1016/j.jpsychores.2004.09.006 – ident: e_1_2_9_31_1 doi: 10.1001/jama.2014.14173 – volume-title: Using Local Data to Monitor the Health Needs of People with Learning Disabilities year: 2012 ident: e_1_2_9_5_1 contributor: fullname: Glover G – volume: 57 start-page: 64 year: 2007 ident: e_1_2_9_2_1 article-title: Health problems of people with intellectual disabilities: the impact for general practice publication-title: Br J Gen Pract contributor: fullname: Straetmans JM – ident: e_1_2_9_11_1 doi: 10.1111/j.1365-2648.2011.05860.x – ident: e_1_2_9_16_1 doi: 10.1177/014572179802400504 – volume: 60 start-page: 746 year: 2016 ident: e_1_2_9_12_1 article-title: Desmond‐id: Outcomes of a pilot feasibility study exploring the Hba1c for adults with intellectual disabilities and type 2 diabetes publication-title: J Intellect Disabil Res contributor: fullname: Taggart L – ident: e_1_2_9_27_1 doi: 10.7326/M15-0452 – volume-title: Valuing People: a new strategy for learning disability for the 21st Century year: 2001 ident: e_1_2_9_8_1 contributor: fullname: Department of Health – ident: e_1_2_9_14_1 doi: 10.1111/j.1468-3148.2006.00263.x – ident: e_1_2_9_24_1 doi: 10.1111/j..2002.384.doc.x – ident: e_1_2_9_7_1 doi: 10.1111/j.1467-789X.2006.00296.x – ident: e_1_2_9_15_1 doi: 10.1111/j.1365-2788.2011.01472.x – ident: e_1_2_9_18_1 doi: 10.1177/1074840712471899 – ident: e_1_2_9_30_1 doi: 10.7326/M14-0130 – ident: e_1_2_9_21_1 doi: 10.1186/s13063-015-0832-9 – volume: 7 start-page: 115 year: 2001 ident: e_1_2_9_13_1 article-title: Living circumstances of children and adults with mental retardation or developmental disabilities in the United States, Canada, England and Wales, and Australia publication-title: Dev Disabil Res Rev contributor: fullname: Braddock D – ident: e_1_2_9_23_1 doi: 10.1111/dme.13510 – ident: e_1_2_9_10_1 doi: 10.1002/edn.160 – ident: e_1_2_9_28_1 doi: 10.1186/1741-7015-11-75 – ident: e_1_2_9_4_1 doi: 10.1352/1934-9556-49.3.155 – ident: e_1_2_9_6_1 doi: 10.1111/jir.12100 – volume-title: UK Physical Activity Guidelines year: 2011 ident: e_1_2_9_22_1 contributor: fullname: Department of Health |
SSID | ssj0012939 |
Score | 2.341231 |
Snippet | Aims
To undertake a feasibility randomized controlled trial of supported self‐management vs treatment as usual in a population of adults with obesity, Type 2... To undertake a feasibility randomized controlled trial of supported self-management vs treatment as usual in a population of adults with obesity, Type 2... Abstract Aims To undertake a feasibility randomized controlled trial of supported self‐management vs treatment as usual in a population of adults with obesity,... AimsTo undertake a feasibility randomized controlled trial of supported self‐management vs treatment as usual in a population of adults with obesity, Type 2... AIMSTo undertake a feasibility randomized controlled trial of supported self-management vs treatment as usual in a population of adults with obesity, Type 2... This is the largest published randomized study of Type 2 diabetes mellitus self‐management in community‐living adults with an intellectual disability.... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 776 |
SubjectTerms | Affect Blood Pressure - physiology Body Mass Index Clinical trials Cognitive ability Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - nursing Diabetes Mellitus, Type 2 - psychology Evidence-based medicine Feasibility Studies Female Glycated Hemoglobin - metabolism House Calls - statistics & numerical data Humans Insulin Intellectual disabilities Intellectual Disability - complications Intellectual Disability - nursing Male Management Medication Adherence Middle Aged Obesity - complications Obesity - nursing Physical activity Research: Educational and Psychological Aspects Self-Management - methods Social Support Surveys and Questionnaires |
Title | Randomized controlled feasibility trial of supported self‐management in adults with Type 2 diabetes mellitus and an intellectual disability: OK Diabetes |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdme.13626 https://www.ncbi.nlm.nih.gov/pubmed/29575241 https://www.proquest.com/docview/2038108895 https://search.proquest.com/docview/2018667727 https://pubmed.ncbi.nlm.nih.gov/PMC5969288 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEB7SlJZeQpu-3KRFLT30YljLsi23p9AkhJZtS2ggNyNLI7KQ9YZ695Ce-hN6zs_rL-mM_GCXUCjYRiAZCUYjzePTJ4C3CdaFK-o0dlK6mCZFHZc2sbE2zjitrCochwamX_KTM_XpPDvfgg_DWZiOH2IMuLFmhPWaFdzU7ZqSuzkyRkvmd-AuM8Ywcb5U38YUAu1jZcfBKTnAkvS0QgzjGX_d3IxuWZi3gZLrBmzYgY4fwk5vOoqDTtaPYAubXbg_7ZPju3Cv9_wfw82padxiPvuJTvRY9EsqejQ9GPZahNs6xMKLdnUVuM2daPHS__n1ez4CYsSsEYGfoxUcrhXsswophnCtmDOZ53LVCuqNXjFbO5JCrTry3uX1e_H1s-iRN-0TODs--v7xJO4vYYitUmkeF-gnrsYyQeUniTHSY1Zn6NOJNiTepNQ-M5gUtSVXRSmTpN6RDWKkNcqY0qRPYbtZNPgchM0wJ4ONHrRK8spAv2lt0aZ6orGM4M0gjeqq49qoBh-FRFYFkUWwP8ip6tWtrSTnOxmwlUXweqwmReHsh2lwseI2zO1HzkQRwbNOrGMvsiSrlWyZCIoNgY8NmIR7s6aZXQQy7qzMS6l1BO_C1Pj3wKvD6VEovPj_pnvwgIfdQdP2YXv5Y4UvyQha1q_CZKfv4an8Cwp9CFc |
link.rule.ids | 230,315,783,787,888,1378,11574,27936,27937,46064,46306,46488,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIigXHoVCoIBBHLik2jhO4iAuiLZaaLdIVSv1giLHnogV3WxFkkN74idw5uf1l9TjPLRLhYSQEimSbfmRGXtm_PkzwJsA88Qkeegbzo1vhSL3Ux1oXyqjjBRaJIZCA5ODeHwsPp9EJyvwvj8L0_JDDAE30gw3X5OCU0B6QcvNDAmkxeMbcNOqe0gXN2wfDuRRtJClLQknpwhL0PEKEY5nKLq8Gl0zMa8jJRctWLcE7d6Dr33jW-TJ962mzrf0xR-8jv_bu_twt7NN2YdWmB7ACpbrcHvS7b6vw60utPAQfh-q0sxn0ws0rAO7n9rPAlWHtj1n7joQNi9Y1Zw58nTDKjwtLn_-mg2IGzYtmSMAqRjFgxk5xYyzPh7MZsQWWjcVs7XZl00XzrzYXC07cH3-jn3ZYx20p3oEx7s7Rx_HfnfLg6-FCGM_wWJkckwDFMUoUIoXGOURFuFIKis_QSqLSGGQ5Nr6QkKoICyMNXIU10oolapwA1bLeYlPgOkIY2sR2ge14DT12GJSatShHElMPXjd_-3srCXzyHonyI535sbbg81eDrJOn6uM04YqIcIiD14NyVYTaXtFlThvKA-RB1pvJfHgcSs2Qy08tWaxNZY8SJYEashALN_LKeX0m2P7jtI45VJ68NbJy98bnm1PdtzH03_P-hLWxkeT_Wz_08HeM7hDXWhxcJuwWv9o8Lm1uOr8hVOsK1XZK4Y |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VIqpe-CgUAgUM4sAl1cZxEgdOiHZVKFtQRaUekCLHHotVu9kVSQ7tiZ_AmZ_HL8F2nGiXCgkhJVIk27KdzNjP45dngBcRlpnKyjhUlKrQGEUZ5jKSIRdKKM4ky5QNDUyO0oMT9v40OV2D1_2_MJ0-xBBws57hxmvr4Aull5xczdBytGh6Da6z1CBfi4iOB-0oO4_lnQYntQGWyMsKWRrPUHR1MrqCMK8SJZcBrJuBxrfgS9_2jnhytts25a68_EPW8T87dxtuemRK3nSmdAfWsNqCjYnfe9-CGz6wcBd-HotKzWfTS1TEU93PzaNG4bm2F8QdBkLmmtTtwkmnK1Ljuf71_cds4NuQaUWc_EdNbDSY2CUxoaSPBpOZ1Qpt2pqY2sxNpkt_vJhcnTZwc_GKfDwknthT34OT8f7ntwehP-MhlIzFaZihHqkS8wiZHkVCUI1JmaCOR1wY64lyrhOBUVZKsxJiTESxVgbiCCoFEyIX8TasV_MKHwCRCaYGD5oLJaN24DHFOJcoYz7imAfwvP_YxaKT8ij6JZB534V73wHs9GZQeG-uC2q3Uy0fLAng2ZBs_NBurogK563NY6UDzVolC-B-ZzVDLTQ3oNhApQCyFXsaMliN79WUavrVaX0neZpTzgN46czl7w0v9ib77uHhv2d9Chuf9sbFh3dHh49g0_agI8HtwHrzrcXHBm415RPnVr8BxEYqNQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Randomized+controlled+feasibility+trial+of+supported+self%E2%80%90management+in+adults+with+Type+2+diabetes+mellitus+and+an+intellectual+disability%3A+OK+Diabetes&rft.jtitle=Diabetic+medicine&rft.au=House%2C+A&rft.au=Bryant%2C+L&rft.au=Russell%2C+A+M&rft.au=A+Wright%E2%80%90Hughes&rft.date=2018-06-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0742-3071&rft.eissn=1464-5491&rft.volume=35&rft.issue=6&rft.spage=776&rft.epage=788&rft_id=info:doi/10.1111%2Fdme.13626&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-3071&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-3071&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-3071&client=summon |